Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.

Lion A, Israel AY, Merzon E, Oster H, Weizman A, Luboshits G, Bogen B, Mittelman M, Firer MA

DOI: 10.3389/fimmu.2026.1882291
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1882291,
  title = {Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.},
  author = {Lion A and Israel AY and Merzon E and Oster H and Weizman A and Luboshits G and Bogen B and Mittelman M and Firer MA},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1882291},
  url = {https://doi.org/10.3389/fimmu.2026.1882291}
}

RIS

TY  - JOUR
TI  - Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.
AU  - Lion A
AU  - Israel AY
AU  - Merzon E
AU  - Oster H
AU  - Weizman A
AU  - Luboshits G
AU  - Bogen B
AU  - Mittelman M
AU  - Firer MA
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1882291
UR  - https://doi.org/10.3389/fimmu.2026.1882291
ER  -

APA

A, L., AY, I., E, M., H, O., A, W., G, L., B, B., M, M., & MA, F. (2026). Simvastatin as an immunomodulator and anti-myeloma agent - epidemiological, in vitro and murine model studies.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1882291

Source records

pubmed · retrieved 2026-09-25T20:44:10.100Z